Share
Download
Cite
+ Favorites
Share
Download
Cite
+ Favorites
RESEARCH
Don't Believe the Hype; Remdesivir in the Treatment of COVID-19 .
OrthoEvidence Journal (OE Journal) - OE Original
OE Journal. 2020;8(14):2Remdesivir quickly became one of the most talked-about COVID-19 treatments, supported by an emergency authorization and heavy national investment. Yet when the evidence is examined through a GRADE lens, confidence in its benefit is far less certain than many guidelines imply. Trial data show mixed effects on mortality and only modest signals for faster recovery, with no major safety advantage. This explains why some guidelines issue only weak recommendations while others appear more confident—the difference largely reflects how each panel weighs limited evidence, uncertain benefit, and the value placed on acting quickly during a crisis. Ultimately, remdesivir aligns best with a cautious, weak recommendation until stronger and more consistent data emerge.
Already have an account? Log in
Part of an association? Click here, you may already have full access!
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
